Clinical Report: Recognizing and Diagnosing Anorectal Melanoma
Overview
Anorectal melanoma (AM) is a rare, aggressive malignancy often misdiagnosed due to nonspecific symptoms and resemblance to benign anorectal conditions. High clinical suspicion and routine histopathological examination of anorectal specimens are critical for early detection, although prognosis remains poor.
Background
Anorectal melanoma accounts for approximately 1.5% of all melanomas and 1–3% of anorectal malignancies excluding adenocarcinomas. It predominantly affects patients in their sixth and seventh decades and may present with rectal bleeding or perianal masses. Amelanotic variants, comprising up to 30% of cases, complicate diagnosis. Due to its rarity and aggressive nature, AM is frequently diagnosed late, often after surgery for presumed benign disease.
Data Highlights
This retrospective multicenter study included cases treated from 2013 to 2023 across four high-volume Italian centers. Data collected encompassed presenting symptoms, tumor characteristics, diagnostic procedures, treatment modalities, and follow-up outcomes. Histopathological diagnosis was mandatory for inclusion, with a minimum follow-up of 12 months or until death.
Key Findings
AM is frequently misdiagnosed due to nonspecific symptoms and clinical similarity to benign anorectal lesions such as thrombosed hemorrhoids.
Amelanotic variants represent 10%–30% of cases, increasing diagnostic difficulty.
Routine histopathological examination of all anorectal surgical specimens is strongly recommended to avoid missed diagnoses.
Most patients present with locally advanced disease or distant metastases at diagnosis, contributing to poor prognosis.
Diagnostic differential should include rectal adenocarcinoma, leiomyosarcoma, epidermoid carcinoma, carcinoid tumors, and benign polypoid lesions.
Management should be centralized in high-volume referral centers with multidisciplinary teams due to treatment complexity.
Clinical Implications
Clinicians should maintain a high index of suspicion for AM in patients presenting with rectal bleeding or perianal masses, especially when lesions appear atypical or pigmented. Multiple biopsies and routine histopathological analysis of all anorectal specimens, even those presumed benign, are essential to improve early detection. Referral to specialized centers is advised for optimal management.
Conclusion
Anorectal melanoma remains a diagnostically challenging and biologically aggressive malignancy with poor outcomes. Enhanced clinical awareness and systematic pathology protocols are vital to improve early diagnosis and guide appropriate multidisciplinary treatment.
Patients with preoperative vitamin D deficiency had higher postoperative pain scores and opioid use after mastectomy, including more than triple the odds of moderate to severe pain within 24 hours of surgery.
